These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

421 related items for PubMed ID: 31056398

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Imipridone Anticancer Compounds Ectopically Activate the ClpP Protease and Represent a New Scaffold for Antibiotic Development.
    Jacques S, van der Sloot AM, C Huard C, Coulombe-Huntington J, Tsao S, Tollis S, Bertomeu T, Culp EJ, Pallant D, Cook MA, Bonneil E, Thibault P, Wright GD, Tyers M.
    Genetics; 2020 Apr; 214(4):1103-1120. PubMed ID: 32094149
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Mitochondrial Caseinolytic Protease P: A Possible Novel Prognostic Marker and Therapeutic Target in Cancer.
    Cormio A, Sanguedolce F, Pesce V, Musicco C.
    Int J Mol Sci; 2021 Jun 09; 22(12):. PubMed ID: 34207660
    [Abstract] [Full Text] [Related]

  • 7. Induction of Synthetic Lethality by Activation of Mitochondrial ClpP and Inhibition of HDAC1/2 in Glioblastoma.
    Nguyen TTT, Shang E, Schiffgens S, Torrini C, Shu C, Akman HO, Prabhu VV, Allen JE, Westhoff MA, Karpel-Massler G, Siegelin MD.
    Clin Cancer Res; 2022 May 02; 28(9):1881-1895. PubMed ID: 35417530
    [Abstract] [Full Text] [Related]

  • 8. ONC206 targeting ClpP induces mitochondrial dysfunction and protective autophagy in hepatocellular carcinoma cells.
    Cao J, Cao F, Wang C, Jiao Z, You Y, Wang X, Zhao W.
    Neoplasia; 2024 Sep 02; 55():101015. PubMed ID: 38944913
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of the Mitochondrial Protease ClpP as a Therapeutic Strategy for Human Acute Myeloid Leukemia.
    Cole A, Wang Z, Coyaud E, Voisin V, Gronda M, Jitkova Y, Mattson R, Hurren R, Babovic S, Maclean N, Restall I, Wang X, Jeyaraju DV, Sukhai MA, Prabha S, Bashir S, Ramakrishnan A, Leung E, Qia YH, Zhang N, Combes KR, Ketela T, Lin F, Houry WA, Aman A, Al-Awar R, Zheng W, Wienholds E, Xu CJ, Dick J, Wang JC, Moffat J, Minden MD, Eaves CJ, Bader GD, Hao Z, Kornblau SM, Raught B, Schimmer AD.
    Cancer Cell; 2015 Jun 08; 27(6):864-76. PubMed ID: 26058080
    [Abstract] [Full Text] [Related]

  • 10. Characterization of Gain-of-Function Mutant Provides New Insights into ClpP Structure.
    Ni T, Ye F, Liu X, Zhang J, Liu H, Li J, Zhang Y, Sun Y, Wang M, Luo C, Jiang H, Lan L, Gan J, Zhang A, Zhou H, Yang CG.
    ACS Chem Biol; 2016 Jul 15; 11(7):1964-72. PubMed ID: 27171654
    [Abstract] [Full Text] [Related]

  • 11. ONC201 and imipridones: Anti-cancer compounds with clinical efficacy.
    Prabhu VV, Morrow S, Rahman Kawakibi A, Zhou L, Ralff M, Ray J, Jhaveri A, Ferrarini I, Lee Y, Parker C, Zhang Y, Borsuk R, Chang WI, Honeyman JN, Tavora F, Carneiro B, Raufi A, Huntington K, Carlsen L, Louie A, Safran H, Seyhan AA, Tarapore RS, Schalop L, Stogniew M, Allen JE, Oster W, El-Deiry WS.
    Neoplasia; 2020 Dec 15; 22(12):725-744. PubMed ID: 33142238
    [Abstract] [Full Text] [Related]

  • 12. Selective Activation of Human Caseinolytic Protease P (ClpP).
    Stahl M, Korotkov VS, Balogh D, Kick LM, Gersch M, Pahl A, Kielkowski P, Richter K, Schneider S, Sieber SA.
    Angew Chem Int Ed Engl; 2018 Oct 26; 57(44):14602-14607. PubMed ID: 30129683
    [Abstract] [Full Text] [Related]

  • 13. CLPP deficiency ameliorates neurodegeneration caused by impaired mitochondrial protein synthesis.
    Rumyantseva A, Popovic M, Trifunovic A.
    Brain; 2022 Mar 29; 145(1):92-104. PubMed ID: 35240691
    [Abstract] [Full Text] [Related]

  • 14. Characterization of TR-107, a novel chemical activator of the human mitochondrial protease ClpP.
    Fennell EMJ, Aponte-Collazo LJ, Wynn JD, Drizyte-Miller K, Leung E, Greer YE, Graves PR, Iwanowicz AA, Ashamalla H, Holmuhamedov E, Lang H, Karanewsky DS, Der CJ, Houry WA, Lipkowitz S, Iwanowicz EJ, Graves LM.
    Pharmacol Res Perspect; 2022 Aug 29; 10(4):e00993. PubMed ID: 35929764
    [Abstract] [Full Text] [Related]

  • 15. Crystal structure at 1.9A of E. coli ClpP with a peptide covalently bound at the active site.
    Szyk A, Maurizi MR.
    J Struct Biol; 2006 Oct 29; 156(1):165-74. PubMed ID: 16682229
    [Abstract] [Full Text] [Related]

  • 16. Initial Characterization of the Two ClpP Paralogs of Chlamydia trachomatis Suggests Unique Functionality for Each.
    Wood NA, Chung KY, Blocker AM, Rodrigues de Almeida N, Conda-Sheridan M, Fisher DJ, Ouellette SP.
    J Bacteriol; 2019 Jan 15; 201(2):. PubMed ID: 30396899
    [Abstract] [Full Text] [Related]

  • 17. Perrault syndrome type 3 caused by diverse molecular defects in CLPP.
    Brodie EJ, Zhan H, Saiyed T, Truscott KN, Dougan DA.
    Sci Rep; 2018 Aug 27; 8(1):12862. PubMed ID: 30150665
    [Abstract] [Full Text] [Related]

  • 18. Loss of conserved mitochondrial CLPP and its functions lead to different phenotypes in plants and other organisms.
    Huang S, Petereit J, Millar AH.
    Plant Signal Behav; 2020 Dec 01; 15(12):1831789. PubMed ID: 33073672
    [Abstract] [Full Text] [Related]

  • 19. Phenyl Esters Are Potent Inhibitors of Caseinolytic Protease P and Reveal a Stereogenic Switch for Deoligomerization.
    Hackl MW, Lakemeyer M, Dahmen M, Glaser M, Pahl A, Lorenz-Baath K, Menzel T, Sievers S, Böttcher T, Antes I, Waldmann H, Sieber SA.
    J Am Chem Soc; 2015 Jul 08; 137(26):8475-83. PubMed ID: 26083639
    [Abstract] [Full Text] [Related]

  • 20. Arginine phosphorylation marks proteins for degradation by a Clp protease.
    Trentini DB, Suskiewicz MJ, Heuck A, Kurzbauer R, Deszcz L, Mechtler K, Clausen T.
    Nature; 2016 Nov 03; 539(7627):48-53. PubMed ID: 27749819
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.